Nuwellis (NUWE) Work In Process (2017 - 2026)

Nuwellis (NUWE) reported Work In Process of $138000.0 for Q1 2026, down 0.72% on a YoY basis from $139000.0 in Q1 2025, and up 56.82% quarter-over-quarter from $88000.0 in Q4 2025.

Nuwellis (NUWE) Work In Process (2017 - 2026) Analysis & Trends

Nuwellis has reported Work In Process for 10 years, with the latest figure at $138000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Work In Process fell 0.72% year-over-year to $138000.0; the trailing twelve-month figure through Mar 2026 stood at $138000.0 (down 0.72% YoY), and the FY2025 full-year result was $88000.0, down 32.82% from the prior year.
  • Work In Process for Q1 2026 stood at $138000.0, up from $88000.0 in the prior quarter.
  • The five-year high for Work In Process was $425000.0 in Q2 2025, with the low at $88000.0 in Q4 2025.
  • Historically, Work In Process has averaged $213705.9 across 5 years, with a median of $204000.0 in 2022.
  • The largest YoY upside for Work In Process was 59.88% in 2023 against a maximum downside of 45.05% in 2023.
  • Nuwellis' Work In Process stood at $204000.0 in 2022, then increased by 1.47% to $207000.0 in 2023, then plunged by 36.71% to $131000.0 in 2024, then plunged by 32.82% to $88000.0 in 2025, then surged by 56.82% to $138000.0 in 2026.
  • The last three Work In Process figures came in at $138000.0 (Q1 2026), $88000.0 (Q4 2025), and $251000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Nuwellis 279,710.00 -1.80 Mn 1.68 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 138,000.00
Dec 31, 2025 88,000.00
Sep 30, 2025 251,000.00
Jun 30, 2025 425,000.00
Mar 31, 2025 139,000.00
Dec 31, 2024 131,000.00
Sep 30, 2024 220,000.00
Jun 30, 2024 307,000.00
Mar 31, 2024 198,000.00
Dec 31, 2023 207,000.00
Sep 30, 2023 170,000.00
Jun 30, 2023 275,000.00
Mar 31, 2023 172,000.00
Dec 31, 2022 204,000.00
Sep 30, 2022 223,000.00
Jun 30, 2022 172,000.00
Mar 31, 2022 313,000.00
Dec 31, 2021 276,000.00
Sep 30, 2021 268,000.00
Jun 30, 2021 199,000.00